Log in to your Inderes Free account to see all free content on this page.
Attana
0.01 SEK
0.00 %
Less than 1K followers
ATANA
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Attana
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 1.0 | 4.1 | 1.6 | 0.3 | 0.1 | 0.4 | 2.5 |
| EBITDA | -3.1 | -2.7 | -4.5 | -0.4 | -2.7 | -2.4 | -4.2 | -8.9 |
| EBIT | -3.5 | -2.6 | -10.0 | -0.4 | -3.6 | -3.3 | -3.4 | -10.6 |
| EBIT-% | -2,471.4 % | -265.7 % | -244.1 % | -23.3 % | -1,154.8 % | -2,538.5 % | -763.0 % | -429.9 % |
| Profit before taxes | -4.2 | -3.5 | -12.8 | -0.4 | -3.7 | -3.4 | -3.6 | -11.0 |
| Net income | -4.2 | -3.5 | -12.8 | -0.4 | -3.7 | -3.4 | -3.6 | -11.0 |
Login required
This content is only available for logged in users